Nikolas Balanis
Nikolas Balanis
Verified email at mednet.ucla.edu
Title
Cited by
Cited by
Year
STAT3 and epithelial–mesenchymal transitions in carcinomas
MK Wendt, N Balanis, CR Carlin, WP Schiemann
Jak-stat 3 (2), e28975, 2014
1642014
Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
JW Park, JK Lee, KM Sheu, L Wang, NG Balanis, K Nguyen, BA Smith, ...
Science 362 (6410), 91-95, 2018
1372018
Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway
N Balanis, MK Wendt, BJ Schiemann, Z Wang, WP Schiemann, CR Carlin
Journal of Biological Chemistry 288 (25), 17954-17967, 2013
1202013
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
NA Graham, A Minasyan, A Lomova, A Cass, NG Balanis, M Friedman, ...
Molecular systems biology 13 (2), 914, 2017
572017
A human adult stem cell signature marks aggressive variants across epithelial cancers
BA Smith, NG Balanis, A Nanjundiah, KM Sheu, BL Tsai, Q Zhang, ...
Cell reports 24 (12), 3353-3366. e5, 2018
512018
Pan-cancer convergence to a small-cell neuroendocrine phenotype that shares susceptibilities with hematological malignancies
NG Balanis, KM Sheu, FN Esedebe, SJ Patel, BA Smith, JW Park, ...
Cancer cell 36 (1), 17-34. e7, 2019
422019
The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6
MK Wendt, WK Williams, PE Pascuzzi, NG Balanis, BJ Schiemann, ...
Neoplasia 17 (1), 124-133, 2015
382015
β3 Integrin–EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells
N Balanis, M Yoshigi, MK Wendt, WP Schiemann, CR Carlin
Molecular biology of the cell 22 (22), 4288-4301, 2011
372011
Mutual cross-talk between fibronectin integrins and the EGF receptor: Molecular basis and biological significance
N Balanis, CR Carlin
Cellular logistics 2 (1), 46-51, 2012
202012
Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer
N Balanis, CR Carlin
Molecular and cellular endocrinology 451, 24-30, 2017
132017
A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes
L Wang, BA Smith, NG Balanis, BL Tsai, K Nguyen, MW Cheng, ...
Proceedings of the National Academy of Sciences 117 (1), 563-572, 2020
102020
Mutations in an innate immunity pathway are associated with poor overall survival outcomes and hypoxic signaling in cancer
MM Olcina, NG Balanis, RK Kim, BA Aksoy, J Kodysh, MJ Thompson, ...
Cell reports 25 (13), 3721-3732. e6, 2018
102018
Intracellular C4BPA Levels Regulate NF-κB-Dependent Apoptosis
MM Olcina, RK Kim, NG Balanis, CG Li, R von Eyben, TG Graeber, ...
Iscience 23 (10), 101594, 2020
12020
Making Mistakes Empowers Cancer Cells
NG Balanis, TG Graeber
Trends in cancer 4 (7), 461-463, 2018
12018
Abstract A24: Fibronectin-mediated activation of Stat3 facilitates the resistance of triple negative breast cancer to EGFR-targeted therapies
MK Wendt, N Balanis, C Carlin, W Schiemann
Clinical Cancer Research 18 (10 Supplement), A24-A24, 2012
12012
B06 Time-Resolved RNA-Seq Identifies Transient Gene Expression Changes Following Initial Chemotherapy Challenge in Small-Cell Lung Cancer
DW Shia, V Vuong, E Pecora, N Balanis, P Vijayaraj, C Sen, CJ Aros, ...
Journal of Thoracic Oncology 15 (2), S28-S29, 2020
2020
IA20 Pan-Cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematologic Malignancies
NG Balanis, KM Sheu, ON Witte, TG Graeber
Journal of Thoracic Oncology 15 (2), S7, 2020
2020
TMIC-26. PRECLINICAL MODEL SYSTEMS OF GLIOBLASTOMA REVEAL MICROENVIRONMENTAL PROGRAMS AND DEPENDENCIES IN PATIENT TUMORS
N Bayley, C Tse, L Baufeld, L Gosa, W Yan, H Zhu, N Balanis, ...
Neuro-Oncology 21 (Suppl 6), vi253, 2019
2019
A linear mixed model approach to gene expression-tumor aneuploidy association studies
DW Yao, NG Balanis, E Eskin, TG Graeber
Scientific reports 9 (1), 1-8, 2019
2019
MP57-09 MOLECULAR PROFILING OF SMALL CELL BLADDER CANCER: IMPLICATIONS FOR IMMUNOTHERAPEUTIC STRATEGIES
BA Smith, NG Balanis, B Tsai, JW Park, H Zhang, JW Said, TG Graeber, ...
The Journal of Urology 201 (Supplement 4), e816-e816, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20